Skip to main content
. 2022 Jun 22;158(8):893–899. doi: 10.1001/jamadermatol.2022.2149

Figure 1. Evolution of Antirituximab Antibody (ARA) Serum Levels From Months 12 to 36 in the 13 Patients With ARAs.

Figure 1.

The ARA serum levels were measured by enzyme-linked immunoassay at month 12 following the initial rituximab (RTX) infusion performed at baseline, and at month 36 after the 2 maintenance infusions of RTX at months 12 and 18 (arrows). Relapsing patients are identified in orange. The medians are represented by the horizontal lines.

aP < .05.